| |
Life Sciences
|
|
|
|
| |
|
|
Aeterna Zentaris
Development of medication to fight cancer and other diseases |
|
14% |
|
SGF
Solidarity Fund QFL
Public |
Axcan Pharma Inc.
Development and production of prescription products in the field of gastroenterology |
|
Not available |
|
SGF
TPG Capital (United States)
Private investors |
|
Atrium Innovations
Production and distribution of dietary supplements and health products |
|
5.6% |
|
SGF
Aeterna Laboratories inc.
Solidarity Fund QFL
Private Investor
Fonds d’investissement bioalimentaire |
GeneChem Thérapeutiques
Venture capital fund specialized in research projects and companies involved in genomics |
|
7.3% |
|
SGF
Fonds Bombardier, Shire Pharmaceutical, Solidarity Fund QFL |
MédiaMed Technologies
Innovative technological solutions and consulting services used by hospitals and health care and social services centres. |
|
30% |
|
SGF |
| Medicago
Manufacturing of recombinant proteins for pharmaceutical use |
|
3% |
|
SGF
Other |
Paladin Labs Inc.
Acquiring or in-licensing innovative pharmaceutical products for the Canadian market |
|
1.6% |
|
SGF
Public |
|
Warnex
Specialized analytical, bioanalytical and medical laboratory services |
|
23.8% |
|
SGF
Public |
|
|
|
|